Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results
|
Onconova Therapeutics, Inc. (ONTX)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
02/14/2022 |
SC 13G/A
| CVI Investments, Inc. reports a 0% stake in Onconova Therapeutics, Inc. |
01/08/2021 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 0.1% stake in Onconova Theraupetics Inc. |
02/14/2020 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 2.6% stake in Onconova Therapeutics, Inc. |
02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/14/2020 |
SC 13G/A
| EcoR1 Capital, LLC reports a 0% stake in Onconova Therapeutics, Inc. |
01/13/2020 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 6.3% stake in Onconova Theraupetics Inc. |
11/18/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/25/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
01/03/2019 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 5% stake in Onconova Theraupetics Inc. |
02/14/2018 |
SC 13G/A
| TYNDALL CAPITAL PARTNERS L P reports a 12.4% stake in Onconova Therapeutics, INC. |
01/09/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/14/2017 |
SC 13G/A
| Anson Funds Management LP reports a 2.7% stake in Onconova Theraupetics Inc. |
02/06/2017 |
SC 13G/A
| Baxalta Inc reports a 3.8% stake in – EXIT FILING)* ONCONOVA THERAPEUTICS, INC. |
06/06/2016 |
SC 13G/A
| Baxalta Inc reports a 9.5% stake in ONCONOVA THERAPEUTICS, INC. |
02/29/2016 |
SC 13G/A
| Baxalta Inc reports a 10.5% stake in ONCONOVA THERAPEUTICS, INC. |
05/08/2015 |
SC 13G/A
| BAXTER INTERNATIONAL INC reports a 12% stake in ONCONOVA THERAPEUTICS, INC. |
|
|